DRKS00005986招募中不适用
Multicenter evaluation of MRI-targeted prostate biopsy
niversitätsklinikum Heidelberg0 个研究点目标入组 509 人开始时间: 2014年3月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 509
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 40 Years 至 75 Years（—）
- 性别
- Male
入选标准
- •1. Men referred for an initial prostate biopsy;
- •2. PSA > 3.0 and <50 ng/ml;
- •3. No contraindications to mp-MRI.
排除标准
- •1. Prior prostate biopsy;
- •2. Highly suspicious prostate nodule on DRE;
- •3. Contraindications to prostate biopsy;
- •4. Known prostate cancer.
研究者
相似试验
尚未招募
不适用
Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled StudyProstate CancerNCT05025527Shanghai East Hospital500
已完成
不适用
Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. TransperinealProstate CancerNCT03650153Princess Al-Johara Al-Ibrahim Cancer Research Center165
招募中
不适用
Focal therapy of prostate cancer using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technology: a prospective register study (FOXPRO_REGISTER)C61Malignant neoplasm of prostateDRKS00009021Klinik für Urologie, Universitätsmedizin Mannheim50
已完成
不适用
Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory StudyProstate CancerNCT05612204GCS Ramsay Santé pour l'Enseignement et la Recherche51
招募中
不适用
Efficacy of MRI-guided Prostate Irreversible Electroporation (IRE) therapy; the EMPIRE-trial.Prostate CancerNL-OMON46509Sint Antonius Ziekenhuis40